Exane Derivatives’s AbbVie ABBV Stock Holding History

Exane Derivatives’s Portfolio ABBV Stock Details ABBV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$232K	Sell	1,517 -1,221	-45%	-$187K	0.13%	147
2022 Q1	$444K	Sell	2,738 -527	-16%	-$85.4K	0.13%	203
2021 Q4	$442K	Sell	3,265 -406	-11%	-$55K	0.11%	193
2021 Q3	$396K	Buy	3,671 +35	+1%	+$3.78K	0.1%	222
2021 Q2	$429K	Sell	3,636 -702	-16%	-$82.8K	0.1%	211
2021 Q1	$469K	Sell	4,338 -229	-5%	-$24.8K	0.13%	149
2020 Q4	$489K	Sell	4,567 -6,329	-58%	-$678K	0.14%	154
2020 Q3	$954K	Sell	10,896 -21,753	-67%	-$1.91M	0.28%	82
2020 Q2	$3.21M	Sell	32,649 -8,640	-21%	-$848K	0.86%	27
2020 Q1	$3.15M	Buy	41,289 +26,215	+174%	+$2M	0.88%	22
2019 Q4	$1.35M	Sell	15,074 -12,391	-45%	-$1.11M	0.25%	92
2019 Q3	$2.08M	Buy	27,465 +4,197	+18%	+$318K	0.37%	64
2019 Q2	$1.69M	Buy	23,268 +11,068	+91%	+$805K	0.3%	70
2019 Q1	$983K	Sell	12,200 -36,125	-75%	-$2.91M	0.19%	113
2018 Q4	$4.45M	Buy	48,325 +39,395	+441%	+$3.63M	0.8%	17
2018 Q3	$844K	Sell	8,930 -2,736	-23%	-$259K	0.16%	116
2018 Q2	$1.08M	Sell	11,666 -19,688	-63%	-$1.82M	0.18%	115
2018 Q1	$2.95M	Buy	31,354 +5,281	+20%	+$498K	0.59%	28
2017 Q4	$2.52M	Sell	26,073 -4,726	-15%	-$457K	0.43%	33
2017 Q3	$2.74M	Sell	30,799 -9,710	-24%	-$863K	0.51%	24
2017 Q2	$2.94M	Sell	40,509 -12,571	-24%	-$911K	0.63%	26
2017 Q1	$3.46M	Buy	53,080 +46,110	+662%	+$3M	0.78%	25
2016 Q4	$436K	Sell	6,970 -125,078	-95%	-$7.83M	0.09%	150
2016 Q3	$8.33M	Buy	132,048 +124,908	+1,749%	+$7.88M	1.25%	16
2016 Q2	$442K	Sell	7,140 -3,702	-34%	-$229K	0.07%	138
2016 Q1	$619K	Sell	10,842 -13,287	-55%	-$759K	0.08%	106
2015 Q4	$1.43M	Buy	24,129 +18,146	+303%	+$1.07M	0.2%	58
2015 Q3	$326K	Sell	5,983 -463	-7%	-$25.2K	0.04%	132
2015 Q2	$433K	Sell	6,446 -831	-11%	-$55.8K	0.05%	134
2015 Q1	$426K	Sell	7,277 -2,309	-24%	-$135K	0.05%	135
2014 Q4	$627K	Buy	+9,586	New	+$627K	0.09%	109